Men catheterized for AUR can void more successfully after catheter removal if treated with tamsulosin, and are less likely to need recatheterization

In this preliminary, randomized study, 35 men were pretreated for 3 months with finasteride or placebo

The present results emphasize the usefulness of CISC in ensuring the recovery of bladder function in men with CUR

This study suggests that naftopidil is as effective and safe as tamsulosin

Combined TUMT and BD achieves sufficient subjective and objective improvement and a sustainable long-term effect

While improvement in voiding symptoms and Quality of Life scores were maintained without the need for adjuvant treatment

Clinical trials, sponsored primarily by the manufacturer, have shown dutasteride to be an effective treatment of BPH

The combined (alpha) (1)- and postsynaptically selective (alpha)(2)-blocker GYKI-16084 significantly improved the AUA symptom scores

Treatment with (alpha)(1)-adrenergic receptor blockers improves lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia

Starting administration at 75 mg/day rather than 25mg/day is helpful for LUTS associated with BPH for patients with moderate symptoms, particularly in improving voiding symptoms